Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis

As many as 80% of the 296,000 women and 2,240 men diagnosed with breast cancer in the United States will seek out complementary and alternative medicine (CAM) treatments. One such therapy is Healing Touch (HT), recognized by the National Center for Complementary and Integrative Health (NCCIH) as a t...

Full description

Bibliographic Details
Main Authors: Alice Running, Mark Greenwood, Laura Hildreth, Jade Schmidt
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2016/2503267
id doaj-6a40b6fe8c6f4034b63ee1ef1ea60a4a
record_format Article
spelling doaj-6a40b6fe8c6f4034b63ee1ef1ea60a4a2020-11-24T23:54:20ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882016-01-01201610.1155/2016/25032672503267Bioenergy and Breast Cancer: A Report on Tumor Growth and MetastasisAlice Running0Mark Greenwood1Laura Hildreth2Jade Schmidt3College of Nursing, Montana State University, Bozeman, MT, USADepartment of Mathematical Sciences, Montana State University, Bozeman, MT, USADepartment of Mathematical Sciences, Montana State University, Bozeman, MT, USADepartment of Mathematical Sciences, Montana State University, Bozeman, MT, USAAs many as 80% of the 296,000 women and 2,240 men diagnosed with breast cancer in the United States will seek out complementary and alternative medicine (CAM) treatments. One such therapy is Healing Touch (HT), recognized by the National Center for Complementary and Integrative Health (NCCIH) as a treatment modality. Using a multiple experimental groups design, fifty-six six- to eight-week-old Balb/c mice were injected with 4T1 breast cancer tumor cells and randomly divided into intervention and positive control groups. Five days after tumor cell injection, mice in the intervention groups received HT either daily or every other day for 10 minutes by one HT practitioner. At 15 days after tumor cell injection, tumor size was measured, and metastasis was evaluated by a medical pathologist after necropsy. Tumor size did not differ significantly among the groups (F(3,52)=0.75, p value = 0.53). The presence of metastasis did not differ across groups (chi-square(3) = 3.902, p=0.272) or when compared within an organ (liver: chi-square(3) = 2.507, p=0.474; lungs: chi-square(3) = 3.804, p=0.283; spleen: chi-square(3) = 0.595, p=0.898). However, these results did indicate a moderate, though insignificant, positive impact of HT and highlight the need for continued research into dose, length of treatment, and measurable outcomes (tumor size, metastasis) to provide evidence to suggest application for nursing care.http://dx.doi.org/10.1155/2016/2503267
collection DOAJ
language English
format Article
sources DOAJ
author Alice Running
Mark Greenwood
Laura Hildreth
Jade Schmidt
spellingShingle Alice Running
Mark Greenwood
Laura Hildreth
Jade Schmidt
Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
Evidence-Based Complementary and Alternative Medicine
author_facet Alice Running
Mark Greenwood
Laura Hildreth
Jade Schmidt
author_sort Alice Running
title Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
title_short Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
title_full Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
title_fullStr Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
title_full_unstemmed Bioenergy and Breast Cancer: A Report on Tumor Growth and Metastasis
title_sort bioenergy and breast cancer: a report on tumor growth and metastasis
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2016-01-01
description As many as 80% of the 296,000 women and 2,240 men diagnosed with breast cancer in the United States will seek out complementary and alternative medicine (CAM) treatments. One such therapy is Healing Touch (HT), recognized by the National Center for Complementary and Integrative Health (NCCIH) as a treatment modality. Using a multiple experimental groups design, fifty-six six- to eight-week-old Balb/c mice were injected with 4T1 breast cancer tumor cells and randomly divided into intervention and positive control groups. Five days after tumor cell injection, mice in the intervention groups received HT either daily or every other day for 10 minutes by one HT practitioner. At 15 days after tumor cell injection, tumor size was measured, and metastasis was evaluated by a medical pathologist after necropsy. Tumor size did not differ significantly among the groups (F(3,52)=0.75, p value = 0.53). The presence of metastasis did not differ across groups (chi-square(3) = 3.902, p=0.272) or when compared within an organ (liver: chi-square(3) = 2.507, p=0.474; lungs: chi-square(3) = 3.804, p=0.283; spleen: chi-square(3) = 0.595, p=0.898). However, these results did indicate a moderate, though insignificant, positive impact of HT and highlight the need for continued research into dose, length of treatment, and measurable outcomes (tumor size, metastasis) to provide evidence to suggest application for nursing care.
url http://dx.doi.org/10.1155/2016/2503267
work_keys_str_mv AT alicerunning bioenergyandbreastcancerareportontumorgrowthandmetastasis
AT markgreenwood bioenergyandbreastcancerareportontumorgrowthandmetastasis
AT laurahildreth bioenergyandbreastcancerareportontumorgrowthandmetastasis
AT jadeschmidt bioenergyandbreastcancerareportontumorgrowthandmetastasis
_version_ 1725466117093195776